U.S. health department are reviewing
the safety of AIDS drugs sold by GlaxoSmithKline Plc and
Bristol-Myers Squibb Co after a study showed a higher
heart-attack risk compared with other HIV medicines, the Food
and Drug Administration said on Thursday.

More: - Continued here